Key Documents
Ranjana Advani
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Lymphoma Clinic 875 Blake Wilbur Dr Clinic C Stanford, CA 94305-5820 Tel Work (650) 498-6000
-
Academic Offices
Administrative Contact Sarah Daadi Administrative assistant Email Tel Work 650-725-6456Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > Lymphoma
- Burkitt's Lymphoma
- Burkitt's Lymphoma - Hematology
- Burkitt's Lymphoma - Medical Oncology
- Hodgkin's Disease
Professional Education
| Fellowship: | SUMC - Graduate Medical Education, CA (1996) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1991) |
| Residency: | SUMC - Graduate Medical Education, CA (1990) |
| Internship: | Santa Clara Valley Medical Center, CA USA (1987) |
| Medical Education: | Bombay University, India (1982) |
Graduate & Fellowship Program Affiliations
Community & International Work
Scientific Focus
Research Interests
Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
Clinical Trials
- A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Second-Line Treatment of Patients With DLBCL Recruiting
- Clinical Trial of PXD101 in Patients With T-Cell Lymphomas Recruiting
- Ph II, Multicenter, Simon 2-Stage of R788 For Relapsed or Refractory T-Cell Lymphoma Recruiting
- Phase I Dose-Escalation Study of Btk Inhibitor PCI-32765 in Recurrent B Cell Lymphoma Recruiting
- Safety and Efficacy of RAD001 in Patients With VelcadeŽ Refractory Mantle Cell Lymphoma Recruiting
Publications
- Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP). Br J Haematol. 2009
- Interim positron emission tomography (PET) scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood. 2009
- Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma. J Clin Oncol. 2009; (26): 4371-7
- The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma. Curr Opin Oncol. 2009; (5): 397-400
- Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leuk Lymphoma. 2009; (11): 1773-84
Trial Administration